Atenção: Todas as denúncias são sigilosas e sua identidade será preservada.
Os campos nome e e-mail são de preenchimento opcional
Metadados | Descrição | Idioma |
---|---|---|
Autor(es): dc.creator | Gonçalves, Alexandre | - |
Autor(es): dc.creator | Tolentino, Chineyder Corrêa | - |
Autor(es): dc.creator | Souza, Fernanda Rodrigues de | - |
Autor(es): dc.creator | Huss, Juliana Carla da Costa | - |
Autor(es): dc.creator | Zinato, Karolinne de Lourdes | - |
Autor(es): dc.creator | Lopes, Leandro Teixeira Paranhos | - |
Autor(es): dc.creator | Furlanetto Júnior, Roberto | - |
Autor(es): dc.creator | Neves, Francisco de Assis Rocha | - |
Data de aceite: dc.date.accessioned | 2024-07-22T12:45:09Z | - |
Data de disponibilização: dc.date.available | 2024-07-22T12:45:09Z | - |
Data de envio: dc.date.issued | 2017-12-07 | - |
Data de envio: dc.date.issued | 2017-12-07 | - |
Data de envio: dc.date.issued | 2015-04 | - |
Fonte completa do material: dc.identifier | http://repositorio.unb.br/handle/10482/29983 | - |
Fonte completa do material: dc.identifier | http://dx.doi.org/10.1590/2359-3997000000027 | - |
Fonte: dc.identifier.uri | http://educapes.capes.gov.br/handle/capes/810568 | - |
Descrição: dc.description | Objective: investigate the effect of GC-1 on tolerance to exercise in rats with experimental hypothyroidism. Materials and methods: hypothyroidism was induced with methimazole sodium and perchlorate treatment. Six groups with eight animals were studied: control group (C), hypothyroid group without treatment (HYPO); hypothyroidism treated with physiological doses of tetraiodothyronine (T4) or 10 times higher (10×T4); hypothyroidism treated with equal molar doses of GC-1 (GC-1) or 10 times higher (10×GC-1). After eight weeks, each animal underwent an exercise tolerance test by measuring the time (seconds), in which the rats were swimming with a load attached to their tails without being submerging for more than 10 sec. After the test, the animals were killed, and blood samples were collected for biochemical analysis, and the heart and soleus muscle were removed for weighing and morphometric analysis of the cardiomyocyte. Results: hypothyroidism significantly reduced tolerance to exercise and, treatment with GC-1 1× or T4 in physiological doses recover tolerance test to normal parameters. However, high doses of T4 also decreased tolerance to physical exercise. Conversely, ten times higher doses of GC-1 did not impair tolerance to exercise. Interestingly, hypothyroidism, treated or not with T4 in a physiological range, GC-1 or even high doses of GC-1 (10X) did not change cardiomyocyte diameters and relative weight of the soleus muscle. In contrast, higher doses of T4 significantly increased cardiomyocyte diameter and induced atrophy of the soleus muscle. Conclusion: unlike T4, GC-1 in high doses did not modify tolerance to physical exercise in the rats with hypothyroidism. | - |
Formato: dc.format | application/pdf | - |
Idioma: dc.language | en | - |
Publicador: dc.publisher | Sociedade Brasileira de Endocrinologia e Metabologia | - |
Direitos: dc.rights | Acesso Aberto | - |
Direitos: dc.rights | Archives of Endocrinology and Metabolism - This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY NC 3.0). Fonte: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972015000200141&lng=en&nrm=iso. Acesso em: 16 mar. 2018. | - |
Palavras-chave: dc.subject | Exercícios físicos | - |
Palavras-chave: dc.subject | Tireóide | - |
Palavras-chave: dc.subject | Hipotiroidismo | - |
Título: dc.title | The thyroid hormone receptor β-selective agonist GC-1 does not affect tolerance to exercise in hypothyroid rats | - |
Aparece nas coleções: | Repositório Institucional – UNB |
O Portal eduCAPES é oferecido ao usuário, condicionado à aceitação dos termos, condições e avisos contidos aqui e sem modificações. A CAPES poderá modificar o conteúdo ou formato deste site ou acabar com a sua operação ou suas ferramentas a seu critério único e sem aviso prévio. Ao acessar este portal, você, usuário pessoa física ou jurídica, se declara compreender e aceitar as condições aqui estabelecidas, da seguinte forma: